AMPK activation in response to leptin signaling reduces tau phosphorylation [369, 370], and compounds that activate AMPK, such as resveratrol and metformin, stimulate Aβ metabolism, reduce mitochondrial dysfunction, and improve AD pathology [371–373]. This evidence concerns the gene MAPT and Alzheimer disease.